UC Santa Cruz Foundation President Gary Novack was recently selected as a member of the Glaucoma Research Society, a public interest, nonprofit scientific association of outstanding glaucoma researchers. The society provides a forum to discuss and stimulate compelling research to prevent glaucoma-related disability worldwide; the organization consists of fewer than 100 scientists whose investigations lead the field of glaucoma.
A UCSC alumnus, Novack has served as president of the foundation since 2009 and has been a board trustee for 14 years. He was a UC Regent from 2003 to 2005.
Novack holds a Bachelor of Arts degree from UCSC with a major in biology and minors in physics and religious studies (Kresge '73). He received his Ph.D. from UC Davis in pharmacology/toxicology and his post-doctoral training in neurophysiology from UCLA.
Novack is currently the founder and president of PharmaLogic, a firm that provides research and development consulting services to pharmaceuticals and medical device firms. PharmaLogic has played a key role of over 30 marketed products to treat glaucoma, ocular inflammation, macular degeneration and psoriasis. Novack's past achievements in glaucoma research will contribute to new ideas and collaborative research that will benefit those with glaucoma worldwide.
